BRIACELL THERAPEUTICS CORP. Public Float
BRIACELL THERAPEUTICS CORP. (BCTX) had Public Float of $94.48 million as of 2025-01-31, per its 10-K filed 2025-10-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-10-16
- 2025-01-31: Entity Public Float $94.48M.
- 2024-01-31: Entity Public Float $63.69M.
- 2023-01-31: Entity Public Float $105.16M.
- 2022-01-31: Entity Public Float $88.63M.
| Period end | Entity Public Float |
|---|---|
| 2025-01-31 | $94.48M 10-K · filed 2025-10-16 |
| 2024-01-31 | $63.69M 10-K · filed 2024-10-29 |
| 2023-01-31 | $105.16M 10-K · filed 2023-10-25 |
| 2022-01-31 | $88.63M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |